Optimal treatment strategy of fremanezumab in migraine prevention: a systematic review with network meta-analysis of randomized clinical trials

Identifying the optimal fremanezumab treatment strategy is crucial in treating patients with migraines. The optimal strategy was investigated by assessing the cumulative 50% reduction rate (50%CRR), cumulative 75% reduction rate (75%CRR), reduction in the number of migraine days, treatment-related a...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, I-Hsin, Wu, Po-Chien, Lee, Ya-Han, Kang, Yi-No
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596067/
https://www.ncbi.nlm.nih.gov/pubmed/33122778
http://dx.doi.org/10.1038/s41598-020-75602-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596067/
https://www.ncbi.nlm.nih.gov/pubmed/33122778
http://dx.doi.org/10.1038/s41598-020-75602-8

Ejemplares similares